Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) and other mineral exploration companies are working to take advantage of the surge in cobalt’s spot price during 2017 to a nine-year high, with a 120 percent rise during the year reported and predictions that demand will continue in 2018 to fuel technology-friendly markets. An article discussing this reads: “Well-aware of the shifting supply scene, Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) is focusing its attention on developing its mining interests in Canada (http://dtn.fm/0Kidg), where the company owns three properties tucked into the core of Ontario’s cobalt belt. Quantum earlier this week announced significant results from an exploration program at its wholly owned Kahuna Property near the town of Cobalt. … Quantum also recently published the results of assays from its exploration program at its Nipissing Lorrain mine (http://dtn.fm/36TeE).”
To view the full article, visit http://dtn.fm/9zDKS
About Quantum Cobalt Corp.
Quantum Cobalt Corp. (formerly Bravura Ventures Corp.) is building one of the largest land packages in the prolific mining town of Cobalt, Ontario, Canada, with the option to acquire 100 percent of the Nipissing Lorrain Cobalt Property that includes two separate claims. The property, consisting of 29 claim units for approximately 464 hectares, is located in an historically mined area with rich deposits of cobalt, silver and nickel. The area is easily accessible by road with power and infrastructure nearby. For more information, visit the company’s website at www.QuantumCobalt.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Friday, December 29, 2017
Net Element, Inc. (NASDAQ: NETE) Delivers Financial Technology Solutions for Today’s Retailers and Consumers
- Net Element mobile payment solutions and services unite the retailer, consumer and market with advanced technology
- The company is keeping up with financial technology (FinTech) trends that are disrupting retail banking in a booming market, with U.S. e-commerce sales projected to surpass $360.3 billion in 2021
- Net Element solutions enable mobile payment options, chat-bots, and expansions to now include cryptocurrency payments
Today’s companies implement smart financial technology (FinTech) solutions in order to keep up with the market and deliver to the next-generation consumer. Net Element, Inc. (NASDAQ: NETE) is an innovative provider of current and comprehensive mobile payment solutions and services, uniting the retailer, consumer and market with advanced technology.
According to an article by The Financial Brand, several FinTech trends are disrupting retail banking (http://dtn.fm/FsFp6) and are must-haves for millennials and today’s consumers. Top favored capabilities required to meet the needs of the current marketplace include payment with mobile devices, bot or messenger-based payments and incorporation of digital currency options. Net Element is delivering these and more.
The company’s PayOnline subsidiary provides a fully-integrated, processor-agnostic electronic and mobile commerce platform. The payment platform simplifies transactions, enables payment security and supports more than 100 payment methods and currencies, as well as credit cards. The PayOnline proprietary software-as-a-service (“SaaS”) is compliant at Level 1 of Payment Card Industry Data Security Standards and is certified with most U.S. and global payment processors.
PayOnline also addresses the customer-centric element of online e-commerce, which is particularly important to new-generation customers in an era of increased efficiency, increased automation and social media. The company brings value-added services by connecting merchants and consumers and enabling interaction via chat-bots with four popular instant messaging apps. This technology is central to the future of retail banking and adds valuable elements to each payment transaction, such as bot-automated updates to the customer regarding payments, adjustments and refunds. These types of services keep the consumer engaged and informed in real-time, at each transaction.
In addition, the company has partnered with Bunker Capital for the launch of a blockchain-based business unit. The new unit will provide a framework to develop and deploy blockchain technology solutions that will connect merchants and consumers, as well as increase efficiencies and expand payment options to allow cryptocurrencies. While still in its infancy, the cryptocurrency market is expected to grow from $541 million in 2017 to $2.9 billion by 2023, which would represent a compound annual growth rate of 32.31 percent (http://dtn.fm/b6SET).
Net Element’s vast solutions for e-commerce for the U.S. and select emerging markets include mobile transaction technologies, online payment tools, restaurant, retail and mobile point of sale solutions, analytical tools, and sales partner solutions. These solutions position the company for growth as FinTech disrupts the booming market, with U.S. e-commerce sales projected to surpass $360.3 billion in 2021 (http://dtn.fm/cKT7f).
For more information, visit the company’s website at www.NetElement.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation. For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
- The company is keeping up with financial technology (FinTech) trends that are disrupting retail banking in a booming market, with U.S. e-commerce sales projected to surpass $360.3 billion in 2021
- Net Element solutions enable mobile payment options, chat-bots, and expansions to now include cryptocurrency payments
Today’s companies implement smart financial technology (FinTech) solutions in order to keep up with the market and deliver to the next-generation consumer. Net Element, Inc. (NASDAQ: NETE) is an innovative provider of current and comprehensive mobile payment solutions and services, uniting the retailer, consumer and market with advanced technology.
According to an article by The Financial Brand, several FinTech trends are disrupting retail banking (http://dtn.fm/FsFp6) and are must-haves for millennials and today’s consumers. Top favored capabilities required to meet the needs of the current marketplace include payment with mobile devices, bot or messenger-based payments and incorporation of digital currency options. Net Element is delivering these and more.
The company’s PayOnline subsidiary provides a fully-integrated, processor-agnostic electronic and mobile commerce platform. The payment platform simplifies transactions, enables payment security and supports more than 100 payment methods and currencies, as well as credit cards. The PayOnline proprietary software-as-a-service (“SaaS”) is compliant at Level 1 of Payment Card Industry Data Security Standards and is certified with most U.S. and global payment processors.
PayOnline also addresses the customer-centric element of online e-commerce, which is particularly important to new-generation customers in an era of increased efficiency, increased automation and social media. The company brings value-added services by connecting merchants and consumers and enabling interaction via chat-bots with four popular instant messaging apps. This technology is central to the future of retail banking and adds valuable elements to each payment transaction, such as bot-automated updates to the customer regarding payments, adjustments and refunds. These types of services keep the consumer engaged and informed in real-time, at each transaction.
In addition, the company has partnered with Bunker Capital for the launch of a blockchain-based business unit. The new unit will provide a framework to develop and deploy blockchain technology solutions that will connect merchants and consumers, as well as increase efficiencies and expand payment options to allow cryptocurrencies. While still in its infancy, the cryptocurrency market is expected to grow from $541 million in 2017 to $2.9 billion by 2023, which would represent a compound annual growth rate of 32.31 percent (http://dtn.fm/b6SET).
Net Element’s vast solutions for e-commerce for the U.S. and select emerging markets include mobile transaction technologies, online payment tools, restaurant, retail and mobile point of sale solutions, analytical tools, and sales partner solutions. These solutions position the company for growth as FinTech disrupts the booming market, with U.S. e-commerce sales projected to surpass $360.3 billion in 2021 (http://dtn.fm/cKT7f).
For more information, visit the company’s website at www.NetElement.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation. For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Entry into Biopharmaceutical Industry Focus of Zacks Small Cap Research Article
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the global life sciences industry, was recently the focus of a publication by Zacks Small Cap Research titled “PBIO: Enters Biopharmaceutical Quality Control Market”. The publication follows the company’s December 20 announcement regarding the release of redesigned software for its Barocycler 2320EXTREME instrument. The publication notes that the new software was created through collaboration with the company’s biopharmaceutical company customers, therefore entering PBIO into the biopharmaceutical market and accelerating the company’s revenue growth. The Zacks report also discusses PBIO recently acquiring all assets of BaroFold, Inc. The company announced the acquisition of assets including all patents, equipment, and intellectual property (“IP”) relating to BaroFold’s PreEMT™ high-pressure protein refolding technology on December 13. The acquired technology is complimentary to PBIO’s proprietary Pressure Cycling Technology (“PCT”), increasing the company’s IP in high-pressure technologies. Among other highlights, Zacks noted that this grants the company the ability to operate in several important areas for biologics research and manufacturing.
To read the full press release, visit http://dtn.fm/Bun13
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To read the full press release, visit http://dtn.fm/Bun13
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Thursday, December 28, 2017
MissionIRNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRA: 6F6) (WKN: A2AKL8) to Present at North American Bitcoin Conference
Blockchain-focused venture builder Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) this morning announced its entry into a partnership with the North American Bitcoin Conference (“TNABC”), the longest running and highest attended financial conference for the bitcoin, blockchain and cryptocurrency industries. Through this partnership, Victory Square and its portfolio companies will be presenting at the forum, which is scheduled to take place January 18-19 in Miami. The company will also be sponsoring a $100,000 investment prize pool for the top three blockchain firms during the anticipated ‘Pitch Your ICO’ session. “We’re extremely excited to be playing such a prominent role at the North American Bitcoin Conference,” Shafin Diamond Tejani, chief executive officer of Victory Square, stated in the news release. “It is the premier conference for blockchain and cryptocurrency and we’re looking forward to using the opportunity to engage with some of the most promising startups and respected blockchain thought-leaders in the world.”
To view the full press release, visit http://dtn.fm/tI4QX
About Victory Square Technologies Inc.
Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.VictorySquare.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/tI4QX
About Victory Square Technologies Inc.
Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.VictorySquare.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Wednesday, December 27, 2017
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Product May Attract Chinese Buyers
- Electric vehicle production increasing demand for lithium
- Chinese firms buying lithium companies
- Chinese investment in Canadian lithium set to grow
- Chinese firms buying lithium companies
- Chinese investment in Canadian lithium set to grow
China is in the market for lithium, according to the China Economic Review (http://dtn.fm/Spf38). Chinese firms, it says, “Have been on a buying spree for lithium… companies over the past year, signing agreements for future supply of the metals. The string of deals come [sic] as auto companies have announced ambitious plans for electric vehicles in the country.” Recently, the Middle Kingdom overtook the U.S. as the country with the largest number of electric vehicles (EVs) on the road. Already with a strong presence in South America, Chinese buyers appear to be looking to the north, snapping up producers in Canada, home to Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF). This junior exploration company, based in Vancouver, is out to acquire brownfield, lithium-rich properties in the U.S. It is hoping to unlock value from overlooked U.S. lithium assets by applying both conventional and modern processing technologies. With a brownfield flagship property at Bristol Lake in the Mojave Desert, chances are high that some Chinese buyer may stop and shop.
“China has emerged as a leader in both the supply of—and demand for—electric vehicles,” a McKinsey report proclaims (http://dtn.fm/rb4vK). In 2016, Chinese manufacturers produced approximately 375,000 EVs, which accounted for 43 percent of global production. Suppliers of the lithium-ion batteries that power these vehicles are fast catching up. Chinese players now account for about 25 percent of global sales. Earlier in December 2017, Private Capital Journal reported the acquisition of Canadian producer Lithium X Energy Corp. (TSX.V: LIX) (OTCQX: LIXXF) for about $257 million by a Chinese partnership (http://dtn.fm/JDe5d). One of those partners also purchased a 20 percent stake in London-listed Bacanora Minerals.
China, which has the world’s largest auto market, is undoubtedly in pole position in the EV race. The Chinese government, seeking to cap carbon emissions, plans to phase out vehicles using gasoline and diesel by 2030, after which time only EVs will be sold. Climbing production of EVs is driving up demand for lithium. Battery-grade lithium has been trading at $20,000 a ton on the Chinese spot market, according to Fortune (http://dtn.fm/6iOym). With prices that lofty, Standard Lithium is stepping up its efforts to get the metal out of the ground. Its first project in San Bernardino County, California, at the Bristol Dry Lake has already started to show signs of promise. This past May, Standard Lithium signed an option agreement to conduct lithium exploration and project development under long-standing mineral claims and permits on the Bristol Dry Lake playa held by National Chloride Corporation of America. Test results from a new geophysical survey of the 35,000-acre Bristol Lake site indicate that high concentrations of lithium-bearing brines are present throughout the company’s mineral lease agreement claims.
Standard Lithium announced this past October that (http://dtn.fm/v8W8B) it had entered into a Memorandum of Understanding with TETRA Technologies, Inc., (NYSE: TTI) to secure access to operating and permitted land of approximately 12,100 acres in Bristol Dry Lake and up to 11,840 acres in the adjacent Cadiz Dry Lake of California’s Mojave Desert. With the recent signing of the MOU with TETRA and the option agreement with National Chloride, the actual combined project area in California now covers over 45,000 acres of the two playa. As a result of working with existing operators, a lot of the required infrastructure is already in place. The property, situated approximately 200 kilometers from Las Vegas and 330 kilometers east of the port of Los Angeles, has electric power and water and is crossed in the northwest by a major paved road (Route 66). There is also a Burlington Northern Santa Fe railroad adjacent to the site, with a purpose-built siding and loading spur-line.
Standard Lithium is also exploring for lithium in the Smackover Formation, which extends through Texas, Arkansas and Louisiana. The formation has produced billions of barrels of brines over the last 80 years from an extensive and extremely well-characterized aquifer.
With demand for lithium continuing to climb, Standard Lithium may soon be hearing a knock on the door as Chinese brokers come calling.
For more information, visit the company’s website at www.StandardLithium.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Creates New Blockchain-based Business Unit Addressing Growing Market Need
An operator of a payments-as-a-service transactional and value-added services platform for enterprises in emerging markets, Net Element (NASDAQ: NETE), recently saw an increase in shares of over 300 percent on December 19, 2017. The surge followed the company’s announcement of a new blockchain-based business unit. An article discussing this reads: “The blockchain-focused business unit will become a decentralized ecosystem that will establish the framework for the provision of new Net Element value-added services. Blockchain technology will be relied on to establish the direct connection between a buyer and a merchant. Thus, the efficiency and simplicity of transactions in the system will increase.”
To view the full article, visit http://dtn.fm/yCCL8
About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the US and selected emerging markets. In the US it aims to grow transactional revenue by innovating SME productivity services such as its cloud based, restaurant and retail point-of-sale solution Aptito. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions such as UAE, Kazakhstan, Kyrgyzstan and Azerbaijan where initiatives have been recently launched. Net Element was named in 2016 by South Florida Business Journal as one of the fastest growing technology companies. Further information is available at www.NetElement.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full article, visit http://dtn.fm/yCCL8
About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the US and selected emerging markets. In the US it aims to grow transactional revenue by innovating SME productivity services such as its cloud based, restaurant and retail point-of-sale solution Aptito. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions such as UAE, Kazakhstan, Kyrgyzstan and Azerbaijan where initiatives have been recently launched. Net Element was named in 2016 by South Florida Business Journal as one of the fastest growing technology companies. Further information is available at www.NetElement.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Expands Lithium Brine Project to Meet Rising Demand
Canadian energy exploration and development company Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is among the companies vying to meet the rising global demand for lithium. An article discussing this reads: “The company announced on December 11, 2017, that it has installed six new separate evaporation ponds at its Bristol Dry Lake property in the Mojave Desert of California. Standard Lithium is taking advantage of the region’s record-high evaporation rates to pre-concentrate brines produced from the project, from where it will be shipped to the company’s testing and processing facilities located at three campuses across North America. In addition, Standard Lithium is undertaking drilling work with four exploration boreholes completed and two more planned. Preliminary results equal and exceed historic data, with the full QA and QC results to be released in the first half of 2018.”
To view the full article, visit http://dtn.fm/M1C5d
About Standard Lithium Ltd.
Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full article, visit http://dtn.fm/M1C5d
About Standard Lithium Ltd.
Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Tuesday, December 26, 2017
India Globalization Capital, Inc. (NYSE: IGC) Targets February 2018 International Patent Filing for Eating Disorder Drug
- Filing for IGC-506 anticipated to be completed in the U.S. in 2019, expanding the company’s patent portfolio; company is looking at pre-clinical trials for three of its combination drugs, possibly creating enhanced valuation
- IGC has pre-clinical trial scheduled in 2018 for IGC-AD1, a combination-therapy drug designed to treat Alzheimer’s
- IGC-506 is a combination therapy developed from cannabis extracts and other compounds that’s designed to treat multiple types of eating disorders in humans and animals
India Globalization Capital, Inc. (NYSE American: IGC) (FRA: IGS1) anticipates a Patent Cooperation Treaty (“PCT”) filing application by February 28, 2018, for IGC-506, which is designed for the treatment of multiple types of eating disorders in humans, as well as animals in the veterinary market. The company anticipates a U.S. and national filing by August 28, 2019, the company announced (http://dtn.fm/MsLB4). A PCT filing is an international patent filing effective in a number of foreign countries (http://dtn.fm/UrSh0).
The company has a number of provisional patent filings, either already made or anticipated in the future, which could raise its valuation. It already has three products, scheduled for pre-clinical trials, featuring provisional filings for patents. These include IGC-501, a cream/patch for the treatment of neuropathic pain; IGC-502, a veterinary market product for the treatment of seizures; and IGC-504 for the treatment of eating disorders in adult humans as well as for the veterinary market. In 2018, IGC anticipates a pre-clinical trial for IGC-ADI, which is designed to treat Alzheimer’s disease.
IGC is a Maryland-based company engaged in the development of cannabis-based combination therapies to treat Alzheimer’s, several endpoints of Parkinson’s, pain, nausea, eating disorders and epilepsy in dogs and cats. It has two lines of businesses. The first, legacy infrastructure, consists of heavy equipment rental, commodities trading and real estate management. The other is canna-pharmaceutical.
IGC-506 is a combination therapy drug, developed from cannabis-extracts and other compounds, designed to treat multiple types of eating disorders. Cannabinoids are chemical compounds that exert a range of effects on the body. The non-psychoactive phytocannabinoid, cannabidiol (CBD), influences many pathways in humans, as well as cats and dogs, and may be used to provide relief for numerous symptoms ranging from pain to eating disorders.
For more information, visit the company’s website at www.IGCInc.us
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Looks to Blockchain Technology as Possible Solution for Issues Facing Cannabis Industry
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced plans to leverage its existing team of technology and health care experts in order to develop methods of utilizing blockchain technology in areas such as product identification assurance (PIA). The importance of PIA was reaffirmed in a recent study published by JAMA, which indicated that nearly 70 percent of all cannabidiol products sold online are mislabeled. “We understand the unique challenges facing the cannabis industry and believe that our team has the expertise to be the first to create meaningful solutions to address these issues using distributed ledgers inherent in blockchain technology,” Ram Mukunda, CEO of IGC, stated in the news release. “As we work to develop blockchain in the rollout of Hyalolex, our goal would be to establish a universal cannabis platform applicable to solving multiple industry challenges facing dispensaries and consumers. This would include addressing issues such as transactional difficulties, inadequate product labeling, product identification assurance (PIA) and product origin assurance.”
To view the full press release, visit http://dtn.fm/6wnF3
About IGC
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.igcinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/6wnF3
About IGC
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.igcinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Friday, December 22, 2017
MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Aims to Unlock Value in U.S. Assets
As demand increases and utilities around the globe employ lithium batteries on micro and macro levels, Standard Lithium. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is planning to unlock value from overlooked U.S. assets. A recent article highlights the company’s aim to apply new processes and technologies in leveraging its extensive California assets and others in the U.S., indicating, “The company is also exploring for lithium in the Smackover Formation, which extends through Texas, Arkansas and Louisiana, and has produced billions of barrels of brines over the last 80 years from an extensive and extremely well-characterized aquifer.”
To view the full article, visit http://dtn.fm/BS61x
About Standard Lithium Ltd.
Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full article, visit http://dtn.fm/BS61x
About Standard Lithium Ltd.
Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Cobalt Producer Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) Poised to Reap Resource-hungry Market Benefits
As electric vehicles prepare to take the road in numbers unheard of since the advent of the internal combustion engine, Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) is poised to join a number of mineral exploration companies in profiting from the demand for tech-friendly resources. Industry analysts predict that the new vigor in demand for EV production will continue to fuel efforts to secure the minerals that provide power to EV batteries. An article discussing this reads: “Bloomberg has estimated that EVs will enjoy a 2 percent share of the auto market by 2020. This is expected to rise to 8 percent by 2025, to 20 percent by 2030, and to at least 35 percent by 2040. These statistics have fueled a great deal of anxiety in some corners, with automakers scrambling to secure supplies. They have also given rise to a very tight global cobalt market. Recently, Volkswagen announced it had failed to secure a long-term supplier for cobalt. In September, the German carmaker put out a tender seeking a five-year supply of the strategic metal at a fixed price but there were no takers at the offer price. Demand for cobalt is expected to surge from 2k tonnes in 2017 to over 300k tonnes by 2030, a stupendous 14,900 percent increase that will see prices reach record levels.”
To read the full article, visit http://dtn.fm/NbJK7
About Quantum Cobalt Corp.
Quantum Cobalt Corp. (formerly Bravura Ventures Corp.) is building one of the largest land packages in the prolific mining town of Cobalt, Ontario, Canada, with the option to acquire 100 percent of the Nipissing Lorrain Cobalt Property that includes two separate claims. The property, consisting of 29 claim units for approximately 464 hectares, is located in an historically mined area with rich deposits of cobalt, silver and nickel. The area is easily accessible by road with power and infrastructure nearby. For more information, visit the company’s website at www.QuantumCobalt.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To read the full article, visit http://dtn.fm/NbJK7
About Quantum Cobalt Corp.
Quantum Cobalt Corp. (formerly Bravura Ventures Corp.) is building one of the largest land packages in the prolific mining town of Cobalt, Ontario, Canada, with the option to acquire 100 percent of the Nipissing Lorrain Cobalt Property that includes two separate claims. The property, consisting of 29 claim units for approximately 464 hectares, is located in an historically mined area with rich deposits of cobalt, silver and nickel. The area is easily accessible by road with power and infrastructure nearby. For more information, visit the company’s website at www.QuantumCobalt.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Thursday, December 21, 2017
Sage Therapeutics, Inc. (NASDAQ: SAGE) Builds Dreams of Depression Treatment Successes
- Millions of people in North America report major depression concerns
- Sage Therapeutics drug trials return dramatic data
- Testing phase targets central nervous system biomolecule receptors
Biopharmaceutical company Sage Therapeutics, Inc. (NASDAQ: SAGE) is reporting optimism over recent product testing in its efforts to reduce the debilitating effects of central nervous system disorders such as depression in its varied forms. Company CEO Jeff Jonas told a CNBC interviewer this month that he’s hopeful a pill now known as SAGE-217 may even become as prominently recognized as Prozac in the treatment of major depressive disorder (MDD), or clinical depression (http://dtn.fm/p80OC).
“What we saw in this study was a reduction to such a degree that two-thirds of the patients nearly achieved remission, which is elimination of depressive systems, by two weeks… I’ve been doing this for 20 years, and I don’t think I’ve ever seen data this dramatic in a mid-stage trial,” Jonas said during the ‘Power Lunch’ interview.
MDD reportedly affects millions of people in North America, the principle geographical region where it is recognized and treated globally. In 2015, nearly seven percent of U.S. adults reported episodes of MDD that affected aspects of their lives including appetite, sleep, interest in once-enjoyable activities, ability to reason and act, and, in some cases, their will to live, according to Healthline Media (http://dtn.fm/2rbKm).
“There are currently significant gaps in the disease management of depression and our development goal at Sage is to change patients’ expectations by transforming the treatment landscape for MDD,” Dr. Steve Kanes, chief medical officer for Sage Therapeutics, stated in a December news release (http://dtn.fm/7oCR9).
In November, Sage Therapeutics reported its lead experimental product for intravenously treating postpartum depression — brexanolone, or SAGE-547 — helped women with moderate to severe afflictions by statistically significant margins over placebo in third-stage testing (http://dtn.fm/bD69X). SAGE-217 has just completed smaller scale second-stage testing, but Jonas said the company is confident that the positive results will continue through the next phase of trials as it works with the FDA on potential market approval.
SAGE-217 would offer a side effect and efficacy profile distinct from any other product, as the company works on “brand new science” to calm down the brain, according to Jonas.
“The one challenge is that people are going to have to clear their minds of the old style of thinking about what … anti-depressants do and what they need to do. So we’re going to have to be very innovative in designing our Phase 3 program. We obviously will need one, and that’s the work we’re undertaking right now,” he said.
The company’s products target gamma-Aminobutyric acid (GABA) system receptors in the central nervous system, which are responsible for reducing neuronal excitability and N-methyl-D-aspartate (NMDA) system receptors in nerve cells. The double-blind SAGE-217 test involved 89 eligible patients who reported no serious or severe adverse side effects during the trials involving the neuroactive steroid’s effects on the GABA system. In addition to MDD, the trials analyze the drug’s response to postpartum depression and to the movement disorders essential tremor and Parkinson’s disease.
The company’s portfolio includes anticipated product trials for SAGE-718, which will target “cerebrosterol deficit disorders, Anti-NMDA Receptor Encephalitis and other indications involving NMDA receptor hypofunction” in the hope of eventually developing ways of treating conditions such as depression, Alzheimer’s disease, attention deficit hyperactivity disorder, schizophrenia, Huntington’s disease, and neuropathic pain.
For more information, visit the company’s website at www.SageRx.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Expands Its Interests in California
- Demand for lithium expected to increase by over 300 percent by 2025
- Standard Lithium has a strong technical team to process established reserves
- The company is exploring other potentially highly lucrative reserves
On the back of the growing global demand for cleaner energy, lithium producers are leading the way by providing the essential element for batteries in electric cars. Fortune magazine reports that the production of electric cars will increase by almost three percent by 2020 and 10 percent by 2025 (http://dtn.fm/fD813). The demand for lithium is set to increase by more than 300 percent over the next eight years, prompting lithium mining companies to step up their efforts for a leading position on the market. Already a prominent lithium developer, Vancouver-based energy exploration and development company Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is expanding its operations and recently announced an expansion of its lithium brine project in California.
The company announced on December 11, 2017, that it has installed six new separate evaporation ponds at its Bristol Dry Lake property in the Mojave Desert of California. Standard Lithium is taking advantage of the region’s record-high evaporation rates to pre-concentrate brines produced from the project, from where it will be shipped to the company’s testing and processing facilities located at three campuses across North America. In addition, Standard Lithium is undertaking drilling work with four exploration boreholes completed and two more planned. Preliminary results equal and exceed historic data, with the full QA and QC results to be released in the first half of 2018.
The Bristol Dry Lake project covers an area of over 33,000 acres including both patented and placer mineral claims and private property. Recently acquired geophysical data indicates that the basin is deep and expansive. Historical drill samples have shown lithium contents of over 100mg/l over the drilled interval. Bristol Dry Lake is an established mining area with world class infrastructure at the project, paved road and rail access, water and electricity. Standard Lithium has inked agreements with two of the established brine producers in the region, National Chloride Corporation of America and TETRA Technologies (NYSE: TTI), to explore and develop the area for potential lithium production. Under the agreements, the company can conduct exploration, brine sampling, extraction, evaporation and process testing.
Standard Lithium has brought together a strong team of scientists and process engineers to advance the project by applying a hybrid approach, utilizing both conventional and modern extraction processes. With a focus on producing high-quality lithium at low cost to meet global demand, Standard Lithium’s mission is to develop lithium resources that can be brought into production quickly while minimizing project and process risks.
Standard Lithium has also entered into an agreement to explore the highly promising brines over an area of approximately 30,000 acres in the Smackover Formation, which transverses Texas, Arkansas and Louisiana. This offers a low-risk investment with good potential returns in a region with well understood geology. It also has a long history of brine production and the infrastructure for profitable mineral extraction. Historical analysis of the Arkansas Smackover Fromation showed a lithium content of 365mg/l.
Lithium is set to become a highly valuable commodity as the world turns to vehicles driven by electric batteries instead of fossil fuels and, also, with the exponential increase in the use of mobile devices. As the global demand for lithium takes off, producers around the world are expected to have a hard time keeping up, resulting in a market deficit. Standard Lithium has secured reserves to process and will continue to develop other opportunities to meet worldwide demand.
For more information, visit the company’s website at www.StandardLithium.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Net Element, Inc. (NASDAQ: NETE) Shares Surge 250% after Launch of New Blockchain Unit
- Net Element, Inc. shares registered an initial increase of over 300 percent after the announcement of a new blockchain unit
- The project will be executed in partnership with Bunker Capital
- Net Element’s move follows several similar announcements and the growth of the cryptocurrency market to over $600 billion in December 2017
Net Element, Inc. (NASDAQ: NETE) saw an increase in shares of over 300 percent on December 19, 2017, after the company announced the launch of a new blockchain-based business unit. Eventually, the initial increase slowed down, but company shares were still up around 254 percent at the time of Market Insider’s report the next day (http://dtn.fm/fKUr5).
Net Element is a technology-driven enterprise aimed at developing specialized mobile payment solutions and transaction services. Some of the company’s key developments include restaurant point of sale solutions, retail and mobile point of sale solutions, analytical tools, sales partner solutions, online payment tools and mobile transaction technologies.
The blockchain-focused business unit will become a decentralized ecosystem that will establish the framework for the provision of new Net Element value-added services. Blockchain technology will be relied on to establish the direct connection between a buyer and a merchant. Thus, the efficiency and simplicity of transactions in the system will increase.
Additionally, Net Element has announced that the new unit will invest in new projects aimed at decentralizing payment processes. These projects will preferably combine real world applications and blockchain cryptocurrencies to address a growing market need.
In November 2017, the global cryptocurrency market surpassed the $300 billion mark (http://dtn.fm/TYIj5). The new development was the result of a massive surge in the price of bitcoin, as well as ethereum. As of December, the market capitalization for cryptocurrencies reached $600 billion, a remarkable surge from $17 billion in January 2017 (http://dtn.fm/1Wmzv). The rapid upward shift is demonstrative of the growing interest in blockchain adoption and cryptocurrency payments.
Experts predict that major cryptocurrencies are here to stay (http://dtn.fm/uaY38). Some also suggest that brand new cryptocurrencies will enter the big game in 2018 and beyond. While it’s impossible to determine how many blockchain protocols will survive and thrive, the market still has room available for new players.
Net Element CEO Oleg Firer said that we’re currently at the dawn of an evolution that focuses on innovative digital payment methods. The creation of the company’s new blockchain unit will increase transparency and compliance assurance. The unit will also enable the provision of value-added services to over 20 million ecommerce clients that are already relying on Net Element services.
The deployment of Net Element’s blockchain technology unit will occur in partnership with Bunker Capital – a company that describes itself as a cryptocurrency pioneer. The company’s range of services includes preparation and promotion of ICOs, as well as strategic investment banking and consulting in the field of cryptocurrency adoption. Bunker Capital CEO Remy Jacobson said in a news release that the company is looking forward to its joint project with Net Element for the purpose of developing innovative blockchain solutions in the payment industry.
Net Element’s announcement isn’t the first one in the field of blockchain technology adoption. A Chinese company called Future Fintech Group (NASDAQ: FTFT) previously announced that it will be making a switch from selling juices to cryptocurrency financial technology development. Company shares saw an almost immediate increase of 221 percent.
For more information, visit the company’s website at www.NetElement.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) Enters LOI for Merger with Tokyo Smoke; Announces Investment from Aphria Inc.
Premium cannabis lifestyle brand DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) this morning announced its entry into a binding letter of intent setting out the terms pursuant to which it proposes to acquire all of the issued and outstanding shares of Tokyo Smoke. Per the update, the proposed merger will create a uniquely positioned cannabis company combining a best-in-class craft cannabis producer and a retail-focused cannabis company. The combined company is expected to operate under the name “Hiku Brands Company Ltd.” in reference to the brand house containing premium cannabis brands DOJA, Tokyo Smoke and Van der Pop. Additionally, DOJA this morning announced its entry into a binding agreement with Aphria Inc. (TSX: APH) (OTCQB: APHQF) pursuant to which Aphria has committed to make a $10 million strategic equity investment in the combined company. With this investment, the newly-combined company is expected to have a robust cash position of roughly $31 million with which to expand its cannabis production capacity, grow its retail footprint and add select brands to its portfolio through complementary acquisitions.
To view the full press release, visit http://dtn.fm/mnl6H
About DOJA Cannabis Company Limited
DOJA™ is a premium cannabis lifestyle brand growing high-quality handcrafted cannabis flower. DOJA’s wholly owned subsidiary is a licensed producer of cannabis under the ACMPR that has requested its Pre-Sales License Inspection, the last step prior to receiving a license to sell cannabis under the ACMPR. DOJA’s state-of-the-art ACMPR licensed production facility is located in the heart of British Columbia’s picturesque Okanagan Valley. DOJA was founded by the proven entrepreneurial team that started SAXX Underwear®. For more information, visit the company’s website at www.DOJA.life
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) Names Bluzelle CEO Pavel Bains as Strategic Advisor
Blockchain technology-focused venture builder Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) this morning announced that it has added blockchain and cryptocurrency pioneer Pavel Bains, CEO of Bluzelle Platform Pte. Ltd., as its new strategic advisor. Victory Square has also been invited to participate in Bluzelle’s early contributors’ round for its upcoming token sale. As a result, it has will be purchasing a $500,000 allocation of Bluzelle tokens, receiving an additional 25 percent of bonus tokens for being an early contributor. “Victory Square exists to enable the next generation of entrepreneurs to experiment, iterate and reinvent both themselves and their businesses to provide innovative solutions to problems with a global reach,” Shafin Diamond Tejani, CEO of Victory Square, stated in the news release. “Pavel is an exemplary individual who has a wealth of experience to impart on other entrepreneurs and we look forward to having him help shape the trajectory of many of the companies in our blockchain portfolio.”
To view the full press release, visit http://dtn.fm/K7T5m
About Victory Square Technologies Inc.
Victory Square is a venture builder that creates, funds and empowers entrepreneurs predominantly focused on Blockchain Technology, Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources and other forms of operational support to help them scale internationally. For more information, visit the company’s website at www.victorysquare.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/K7T5m
About Victory Square Technologies Inc.
Victory Square is a venture builder that creates, funds and empowers entrepreneurs predominantly focused on Blockchain Technology, Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources and other forms of operational support to help them scale internationally. For more information, visit the company’s website at www.victorysquare.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – AzurRx BioPharma, Inc. (NASDAQ: AZRX) Announces Publication of AZX1101 Patent Application
Development stage biopharmaceutical company AzurRx BioPharma, Inc. (NASDAQ: AZRX) this morning announced that the United States Patent and Trademark Office has published patent application number 15/519424, entitled ‘Hybrid Proteinaceous Molecule Capable of Inhibiting at Least One Antibiotic and Pharmaceutical Composition Containing It’, covering the company’s AZX1101 recombinant enzyme for the prevention of antibiotic-induced diarrhea and hospital-acquired C. difficile infections. “We believe that AZX1101, a non-systemic protein, can preserve healthy gastrointestinal flora by inhibiting antibiotics in the GI tract and thus prevent the development of antibiotic induced diarrhea and bacterial infections,” Thijs Spoor, CEO of AzurRx, stated in the news release. “We think the drug has particular application in its potential to greatly reduce the number of C. difficile infections.”
To view the full press release, visit http://dtn.fm/KuOo0
About AzurRx BioPharma, Inc.
AzurRx BioPharma, Inc. (NASDAQ: AZRX) is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the company’s lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infections. The company is headquartered in Brooklyn, NY, with scientific operations based in Langlade, France. Additional information on the company can be found at www.AzurRx.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/KuOo0
About AzurRx BioPharma, Inc.
AzurRx BioPharma, Inc. (NASDAQ: AZRX) is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the company’s lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infections. The company is headquartered in Brooklyn, NY, with scientific operations based in Langlade, France. Additional information on the company can be found at www.AzurRx.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Announces Launch of Blockchain-Focused Business Unit
Net Element, Inc. (NASDAQ: NETE), operator of a payments-as-a-service transactional and value-added services platform for small to medium enterprise in the US and selected emerging markets, today announced that it has launched a new blockchain-focused business unit focused on providing the framework for an unlimited number of value-added services. The new business unit will also intend to identify and invest into unique projects which decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications. Bunker Capital has been partnered with for the development and deployment of blockchain technology-based solutions.
To view the full press release, visit http://dtn.fm/dc57I
About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the US and selected emerging markets. In the US it aims to grow transactional revenue by innovating SME productivity services such as its cloud based, restaurant and retail point-of-sale solution Aptito. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions such as UAE, Kazakhstan, Kyrgyzstan and Azerbaijan where initiatives have been recently launched. Net Element was named in 2016 by South Florida Business Journal as one of the fastest growing technology companies. Further information is available at www.NetElement.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/dc57I
About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the US and selected emerging markets. In the US it aims to grow transactional revenue by innovating SME productivity services such as its cloud based, restaurant and retail point-of-sale solution Aptito. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions such as UAE, Kazakhstan, Kyrgyzstan and Azerbaijan where initiatives have been recently launched. Net Element was named in 2016 by South Florida Business Journal as one of the fastest growing technology companies. Further information is available at www.NetElement.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Wednesday, December 20, 2017
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Major Software Enhancement for Barocycler 2320EXTREME Instrument
Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced the release of extensively redesigned software for its Barocycler 2320EXTREME instrument. The result of a year-long collaborative effort between the PBIO team and customers at one of the world’s largest biopharmaceutical firms, the software upgrade makes the company’s instrument one of the few Good Manufacturing Practices-compliant, computer-controlled sample preparation systems available on the worldwide life sciences market today. “In essence, the 2320EXT offers rapid and reproducible sample preparation for the characterization and quality control of biotherapeutics, now coupled with the assurance of GMP ready software control, achieving a pivotally important requirement for the biopharmaceutical industry,” Dr. Alexander Lazarev, PBIO’s vice president of research and development, stated in the news release.
To view the full press release, visit http://dtn.fm/LPAj0
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of our patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/LPAj0
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of our patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Monday, December 18, 2017
MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Adjourns Voting for Proposals Three and Four from Annual Meeting of Shareholders
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has adjourned the voting for proposals three and four from its notice of annual meeting of shareholders, dated October 5, 2017. Proposal three seeks approval for the grant of 1.9 million shares of common stock, to be granted from time to time to the company’s current and new employees, advisors, directors and consultants by the board of directors. Proposal four seeks approval for the issuance of up to two million shares of the company’s common stock to Bricoleur Partners, L.P. Voting on these two proposals will now be adjourned to December 29, 2017, allowing IGC stockholders additional time to vote. Per the update, stockholders who have not yet voted can do so before December 29, 2017, at 11:59 pm EST by visiting www.ProxyVote.com, calling 800-454-8683 or returning a properly executed proxy card to InvestorCom.
To view the full press release, visit http://dtn.fm/PA46j
About IGC
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.igcinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/PA46j
About IGC
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.igcinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) in Production Mode as Utilities Plug into Grid-Scale Battery Installations
- Demand for large grid-connected lithium batteries climbing
- Demand from electric vehicle industry also rising
- Company expanding exploration and production activities to meet demand
Utilities all around the world are plugging into lithium batteries, a trend that is establishing a new paradigm in the energy industry. Long employed at the micro level to power electrical and electronic devices, lithium batteries are now being employed at the macro level to power entire cities. Power utilities, in an effort to increase reliability of supply, are hooking up giant lithium battery installations to their grids. Already pressured by requirements from the electric vehicle (EV) industry, demand for lithium is set to increase. That development is spurring Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) to intensify its exploration efforts, as it recently added 6,000 more acres to its Bristol Dry Lake Lithium Project. The company is aiming to become a significant low-cost, domestic producer of battery-grade lithium materials.
In February 2017, the largest grid-tied lithium-ion battery system in the U.S. was completed by the Southern California utility San Diego Gas & Electric (SDG&E). This massive energy storage facility was constructed after state officials mandated power companies to add lithium-ion battery storage to their grids, according to Ars Technica (http://dtn.fm/Jkem1). The directive was prompted by a massive methane leak at the Aliso Canyon natural gas storage facility operated by the Southern California Gas Company (SoCalGas). The SDG&E grid-tied lithium-ion storage facility has a 30MW battery system capable of storing 120MWH of energy, enough to serve 20,000 customers for four hours.
Despite its recent commissioning, the scale of the SDG&E facility has already been exceeded. In November 2017, the South Australian government announced the completion of the world’s largest lithium-ion battery just outside the city of Jamestown (http://dtn.fm/FcBj0). The battery behemoth can store 129 MWH of energy and deliver 100MW of power. It was built by Tesla (NASDAQ: TSLA) and is meant to reduce the incidence of recent power outages, one of which affected an area the size of France. Although often confused, power and energy and their units of measurement are distinctly different. Energy (megawatt-hours) can be compared to a reservoir of water that is part of a hydro-electric facility. The larger the size of the dam, the more potential energy the facility possesses. However, power (megawatts), the rate at which that potential energy is converted to usable form, is equally important.
As these developments continue, Standard Lithium is expanding its operations in California. The company recently announced (http://dtn.fm/Fl4gh) its entry into a memorandum of understanding with TETRA Technologies, Inc. (NYSE: TTI) aimed at securing access to additional operating and permitted land of approximately 12,100 acres in Bristol Dry Lake and up to 11,840 acres in the adjacent Cadiz Dry Lake of California’s Mojave Desert. The Bristol Dry Lake is a flat salt dry lake, or playa, that occupies approximately 155 sq. km in a 2,000 sq. km arid drainage basin. The actual project area covers over 25,000 acres of the playa. Standard Lithium recently signed a mineral lease agreement with National Chloride Corporation of America, which has, in the past, mined the near-surface brines to produce concentrated chloride products for various industrial applications. As a result, a lot of the required infrastructure is already in place.
The property, situated approximately 200 km from Las Vegas and 330 km east of the port of Los Angeles, has electric power and water and is crossed in the northwest by a major paved road (Route 66). There is also a Burlington Northern Santa Fe railroad adjacent to the site with a purpose-built siding and loading spur-line.
However, extensive as they are, its California assets are not all that Standard Lithium has to offer. The company is also exploring for lithium in the Smackover Formation, which extends through Texas, Arkansas and Louisiana, and has produced billions of barrels of brines over the last 80 years from an extensive and extremely well-characterized aquifer.
As global demand for lithium continues to climb, Standard Lithium is ramping up its exploration and product activities. The Canada-based junior exploration company continues to acquire lithium rich properties in the U.S. It plans to unlock value from overlooked U.S. lithium assets by applying new technologies and processes.
For more information, visit the company’s website at www.StandardLithium.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Thursday, December 14, 2017
MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Issues Update on Efforts to Roll Out Alzheimer’s Product Hyalolex
India Globalization Capital (NYSE: IGC) today provided investors and interested parties an update on its efforts to launch its principle product for relieving the anxiety, sleep disorders and brain afflictions associated with Alzheimer’s Disease via medical cannabis dispensaries throughout the United States in the next few months. The company stated that dispensaries in Washington, D.C. and Maryland have been identified as initial distribution sites to launch the product once final inventory is secured. Inventory is expected to be secured early next year. Expansion to additional U.S. states will occur next dependent on product procurement and associated compliance achievement. The Medical Marketing Group, Inc., a provider of outsourced product-detailing, education and outreach services, has been engaged to assist with national dispensary expansion ambitions.
To view the full press release, visit http://dtn.fm/Unn1N
About IGC
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information, please visit www.IGCinc.us.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/Unn1N
About IGC
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information, please visit www.IGCinc.us.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) Names Strategic Advisor for Growth of Blockchain Portfolio
Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) today reported appointment of Guy Halford-Thompson to its Advisory Board. A co-founder of BTL Group (TSX-V: BTL) (OTC: BTLLF), Mr. Halford-Thompson is globally recognized as a pioneer and visionary in blockchain technology and his expertise will leverage growth and scaling of Victory Square’s current portfolio of blockchain companies. Mr. Halford-Thompson’s experience includes the investment and incubation of his company, the BTL Group, which was Canada’s first publicly traded blockchain company and has grown to a TSX Venture Exchange market cap of $250M. Of the appointment, Shafin Diamond Tejani, CEO of Victory Square, stated, “Guy has been a thought-leader in the blockchain space for years and has had tremendous success building one of Canada’s premier blockchain companies, the BTL Group. We are extremely excited and fortunate to have him join Victory Square due to his extraordinary vision and foresight on how blockchain will disrupt verticals that our portfolio companies operate in, such as Gaming, Health, Fintech, VR/AR/MR, and AI.”
To view the full press release, visit http://dtn.fm/9Oing
About Victory Square Technologies Inc.
Victory Square is a venture builder that creates, funds and empowers entrepreneurs predominantly focused on Blockchain Technology, Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources and other forms of operational support to help them scale internationally. For more information, visit the company’s website at www.victorysquare.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/9Oing
About Victory Square Technologies Inc.
Victory Square is a venture builder that creates, funds and empowers entrepreneurs predominantly focused on Blockchain Technology, Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources and other forms of operational support to help them scale internationally. For more information, visit the company’s website at www.victorysquare.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Wednesday, December 13, 2017
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Acquires All Assets of BaroFold, Inc.
Pressure BioSciences (OTCQB: PBIO) today reported the acquisition of all assets of BaroFold, Inc. The assets acquired include all patents, equipment, and intellectual property relating to BaroFold’s PreEMT™ high-pressure protein refolding technology. A total of eight issued patents and several pending significantly enhances PBIO’s hold of intellectual property in high-pressure technologies. “In addition to the expected increase in revenue from instrument and consumable sales to customers developing biopharmaceutical manufacturing applications with the PreEMT technology, we expect the BaroFold acquisition to have positive effects on our services revenue as well. In this regard, we plan to continue the biologics contract research services program previously provided by Barofold. This entails extensive revenue-generating studies on the advantages of high-pressure processing in the manufacture of biopharmaceutical products using the patented PreEMT technology. We will also offer manufacturing-scale licenses to biopharmaceutical companies ready to take advantage of the PreEMT technology for more efficient production of their high-quality biological products. We believe such licenses have the potential to generate millions of dollars annually in royalty revenue,” Pressure Biosciences president and CEO Richard T. Schumacher stated in the news release.
To read the full press release, visit http://dtn.fm/3LsbX
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To read the full press release, visit http://dtn.fm/3LsbX
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Monday, December 11, 2017
MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Provides Progress Update on California Lithium Project
Standard Lithium. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) today provided an update on the progress of its development work at the California Lithium Project, which is comprised of Mojave Desert, California area Bristol Dry Lake and Cadiz Dry Lake lithium brine properties. Progress, to date, includes installation of six new separate evaporation ponds on the Bristol Dry Lake Property designed to further assess the role of short-duration passive solar evaporation in processing the project’s lithium brines. Due to extremely high evaporation rates in the project area, previous work demonstrated the potential to concentrate brines from initial lithium concentrations of 146 mg/L to concentrations of 686 mg/L in approximately 7 weeks. (This average concentration was previously reported as 556 mg/L, but has been revised upwards based on final QA/QC data). Additional evaporation tests are continuing in order to assess evaporation rates according to seasonal variations and for the production of large volumes of pre-concentrated brine for shipment to Standard Lithium’s testing facilities across North America for use in ongoing selective lithium extraction processing. In addition, over the next several weeks, a bulk raw-brine sample from the Cadiz Dry Lake Project will be transported to the evaporation ponds to assess pre-concentration of lithium brine from this project.
To view the full press release, visit http://dtn.fm/Tgc3q
About Standard Lithium Ltd.
Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/Tgc3q
About Standard Lithium Ltd.
Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Friday, December 8, 2017
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science
Amid the requirements for maintaining uncompromised sampling in laboratory research, Pressure BioSciences, Inc. (PBIO) is delivering a proprietary technology that can control the preparation of scientific samples in a critical and unprecedented way. This allows researchers to begin their experimentation with the assurance of using biological products that are unmatched in their quality and most likely to produce sound science as a result. An article discussing this reads: “PBIO’s product line is based on a patented, enabling technology platform called pressure cycling technology (PCT), which employs alternating cycles of hydrostatic pressure — ranging between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) — to safely and reproducibly control critical biological processes. For example, one of these processes is lysis, or the breakage of cells. Traditionally, when cells are ruptured for study, they must be broken open using chemicals, blades, metal beads, sound waves or other inadequate methods that can damage and alter the invaluable biomolecules inside the cells. … With PBIO’s pioneering PCT technology, however, the lysis process is controlled like never before.”
To read the full article, visit http://dtn.fm/hH2Qx
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To read the full article, visit http://dtn.fm/hH2Qx
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
WPCS International, Inc., (NASDAQ: WPCS) Subsidiary Signs Definitive Agreement to Merge with DropCar, Inc., Anticipates Name Change and New Ticker Symbol
- Consummation of transaction is anticipated late in calendar 2017, with the merger calling for WPCS to be renamed DropCar after the closing; stock would continue to trade on NASDAQ under a ticker symbol proposed as DCAR
- Spencer Richardson, DropCar co-founder and CEO, would be CEO of the new entity; Sebastian Giordano, WPCS CEO, would serve on newly merged company’s board
- Goal for WPCS is to offer greater shareholder value for its stockholders; when merger is completed, WPCS shareholders would hold 16% of the outstanding common stock in the merged entity while DropCar’s shareholders and advisors would hold the remaining 84%
WPCS International, Inc. (NASDAQ: WPCS), through a wholly-owned subsidiary, has signed a definitive agreement to merge with privately-owned DropCar, Inc. The surviving entity will be named DropCar and the company’s common stock is proposed to trade on the NASDAQ Capital Market under ticker symbol DCAR, according to a December 7, 2017 WPCS SEC S-4 amendment filing.
WPCS will acquire DropCar in an all-stock transaction, the companies announced (http://dtn.fm/hQu6O). The transaction is expected to be consummated late in the fourth quarter of CY 2017. Sebastian Giordano, CEO of WPCS, would serve on the board of the new entity. Spencer Richardson, co-founder and CEO of DropCar, will be CEO of the merged entity.
WPCS is a California-based, low-voltage solutions provider. It installs and services integrated structured cabling, audio-visual and security services for public services, healthcare, energy, and corporate enterprise markets in the U.S. DropCar offers a cloud-based logistics and vehicle support platform designed to reduce the costs and hassles of owning a car in an urban center.
“This is a new and exciting chapter for WPCS,” Giordano said, explaining that the transaction would enable DropCar to “leverage its technology” and grow in the automotive support and logistics market.
Richardson added in a conference call that DropCar plans to expand into major cities worldwide in the future and said that the company already has more than 1,000 subscriber customers (http://dtn.fm/ZMyg4). He called the company “well positioned” to grow as a destructor within the platform of automotive logistics.
When the transaction is completed, it is anticipated that WPCS common stock shareholders would hold 16% of the new entity’s common, while DropCar’s shareholders and advisors would hold the remaining 84%. However, as a December 4, 2017 SEC 8K filing shows, the actual percentages will be tweaked and modified by amendments to the merger agreement. Conditions to the closing call for DropCar to raise at least $4 million prior to consummation.
WPCS International offers full service and low-voltage end-to-end solutions. It can transform organizations with new ways to connect their services, communications, and resourcing.
DropCar, founded and launched in New York City in 2015 offers a cloud-based platform and mobile app that coordinates the activities of trained valets in urban centers. They move cars from secured garages to/from the people who own them. It targets, as its customers, both consumers and businesses, including dealerships and shared mobility companies. They use DropCar’s streamlined logistics for parking, taking the cost and hassle out of owning a car in a congested city.
DropCar recently signed a definitive agreement with Toyota of Manhattan for that dealership to utilize its Enterprise Vehicle Assistance & Logistics (“VAL”) platform, which offers tech logistics in the handling of service and delivery of vehicles.
For more information, visit www.WPCsir.com or www.DropCar.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Subscribe to:
Posts (Atom)